Señales en vivo de AXDX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 may 2024 @ 16:00):

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East...

Stats
Volumen de hoy	15 127.00
Volumen promedio	69 337.00
Capitalización de mercado	20.26M
EPS	$0 ( 2024-03-28 )
Próxima fecha de ganancias	( $-0.720 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.190
ATR14	$0.0110 (1.18%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-17	Phillips Jack	Buy	59 928	Common Stock
2024-04-17	Phillips Jack	Sell	26 735	Common Stock
2024-04-17	Phillips Jack	Sell	59 928	Employee Restricted Stock Units
2024-04-12	Phillips Jack	Buy	59 928	Common Stock
2024-04-12	Phillips Jack	Sell	26 545	Common Stock

INSIDER POWER
96.80
Last 100 transactions
Buy: 51 589 751 \| Sell: 625 027

Accelerate Diagnostics Correlación

10 Correlaciones Más Positivas
APOP	0.891
SONM	0.887
EA	0.881
MRACW	0.861
RBNC	0.857
ALIM	0.856
SVOK	0.849
EQRX	0.848
GHVI	0.847
PAIC	0.843

10 Correlaciones Más Negativas
MMAC	-0.943
PKW	-0.908
PID	-0.902
VONV	-0.9
IUSV	-0.896
PVAL	-0.896
LOPE	-0.895
IOSP	-0.894
TCFC	-0.892
RNDV	-0.89

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Accelerate Diagnostics Finanzas

Annual	2023
Ingresos:	$12.06M
Beneficio Bruto:	$2.55M (21.15 %)
EPS:	$-4.94

FY	2023
Ingresos:	$12.06M
Beneficio Bruto:	$2.55M (21.15 %)
EPS:	$-4.94

FY	2022
Ingresos:	$12.75M
Beneficio Bruto:	$3.30M (25.90 %)
EPS:	$-7.61

FY	2021
Ingresos:	$11.78M
Beneficio Bruto:	$-381 000 (-3.23 %)
EPS:	$-1.260

Financial Reports:

No articles found.

Accelerate Diagnostics

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.